Background: Associations of insulin resistance and hyperglycemia with a panel of liver enzymes have not been well studied in a young, heterogenous Hispanic/Latino population. We aimed to assess the associations of insulin resistance and glycemia with nonalcoholic fatty liver disease (NAFLD), as measured by liver enzymes and the pediatric NAFLD fibrosis index (PNFI), and whether these associations are modified by body mass index and mediated by inflammation or endothelial dysfunction.
liver that can progress to liver inflammation [nonalcoholic steatohepatitis (NASH)] and then fibrosis. 1 Biopsy is the gold standard for identifying and staging NAFLD, but is an invasive procedure and an impractical population-level screening test. It is therefore only selectively used in adults and is even more limited in use among children. Whereas ultrasound and other scanning methods (eg, transient elastography) are often used in evaluating NAFLD, liver enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (GGT)] are also used clinically and in research studies as noninvasive surrogate markers of liver injury and likelihood of NAFLD and fibrosis, along with various noninvasive indices of liver fibrosis such as the pediatric NAFLD fibrosis index (PNFI), which is calculated using clinical markers (age, waist circumference, and triglyceride levels). 3, 4 In adults, higher levels of liver enzymes have been associated cross-sectionally and prospectively with metabolic syndrome, insulin resistance, hyperglycemia, and diabetes. [5] [6] [7] [8] [9] [10] [11] [12] Similar associations have been observed in young children and adolescents. [13] [14] [15] [16] [17] [18] [19] As suggested by these studies, NAFLD could interfere with the insulin signaling pathway and lead to insulin resistance. 20 However, the relationship between hyperglycemia/insulin resistance and NAFLD may be bidirectional or even circular. 21 It is possible that hyperglycemia and insulin resistance could lead to liver injury through various pathways, including increased inflammation and endothelial dysfunction. 22, 23 Whereas both insulin resistance and NAFLD are clearly influenced by obesity, the mechanisms linking insulin resistance to NAFLD, and vice versa, have not been fully elucidated.
Insulin resistance and NAFLD both have particularly high prevalence among Hispanics/Latinos and among obese males in general. 24, 25 Whereas these studies have predominantly included Hispanic/Latino youth and adults of Mexican heritage, data on Hispanics/Latinos of other backgrounds are lacking. In fact, recent data in adults have shown that the prevalence of diabetes and NAFLD varies by Hispanic/Latino background. 26, 27 Associations of insulin resistance and in particular, hyperglycemia, with a panel of liver enzymes have not been well studied in a young, heterogenous Hispanic/Latino population. Given the high prevalence and increasingly early onset of obesity and glucose dysregulation in Hispanic/Latino youth, 28 this is an especially important population in which to investigate these relationships. Therefore, we aimed to assess the associations of insulin resistance and glycemia with liver enzymes and PNFI in Hispanic/Latino children and adolescents; and whether these associations are modified by age, sex, or body mass index (BMI), and/or mediated by biomarkers of inflammation and endothelial dysfunction. These objectives were addressed using the diverse Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth) population aged 8 to 16 years from various Hispanic/Latino backgrounds.
MATERIALS AND METHODS

Study Population
There were 1466 boys and girls, aged 8 to 16 years, recruited into SOL Youth (described previously 29 ) from 4 US cities. 30 Our analytic sample included 1317 participants (see exclusions in the Online Supplement, Supplemental Digital Content 1, http://links.lww.com/JCG/A366). The study was approved by institutional review boards at each site. Written informed consent was obtained from parents/ legal guardians. Assent was obtained from children.
Laboratory Measurements
Morning blood specimens were collected from fasting participants. Measurements included ALT, AST, GGT, fasting glucose, hemoglobin A1c (HbA1c), insulin, adiponectin, plasminogen activator inhibitor (PAI)-1, e-selectin, high-sensitivity C-reactive protein (hs-CRP), high-density lipoprotein cholesterol, triglycerides, cholesterol, low-density lipoprotein cholesterol (calculated using the Fridewald equation). We calculated homeostasis model assessment of insulin resistance (HOMA-IR) as [glucose (in mg/dL)×insulin (in pmol/L)/6/405] 31 (see Online Supplement, Supplemental Digital Content 1, http://links.lww.com/JCG/A366, for more details).
Self-reported Covariates
The following were reported by the child/adolescent and/or the parent: age, sex, Hispanic/Latino background, household income, parental education attainment, alcohol use in the past 30 days, having experienced menarche (girls), and stage of facial hair growth (boys). 32 We created a dichotomous variable for pubertal (having reached menarche for girls and having at least started growing facial hair for boys) or prepubertal status.
Measured Covariates
Centers for Disease Control age-specific and sex-specific BMI percentiles, 33 and National Heart, Lung, and Blood Institute (NHLBI) age-specific, sex-specific, and height-specific diastolic and systolic blood pressure percentiles were calculated. 34 Elevated waist circumference was defined as having an age-specific and sex-specific waist circumference ≥ 90th percentile. 35 We report the number of minutes of moderate/vigorous activity ( ≥ 441 counts/15 s) per day from accelerometers 36 (see Online Supplement, Supplemental Digital Content 1, http://links.lww.com/JCG/A366, for additional details).
Variable Definitions
We defined elevated biomarker levels as follows: ALT > 25 U/L in boys and > 22 U/L in girls 37 ; AST ≥ 37 U/L; GGT ≥ 17 U/L; PNFI ≥ 9 (as suggestive of hepatic fibrosis) 4 ; HOMA-IR ≥ 2.6 (insulin resistance) 38 ; and hyperglycemia as either fasting glucose ≥ 100 mg/dL or HbA1c ≥ 5.7%. 39 We calculated the PNFI as (1/(1+(exp(−lp))))×10, where lp = (−6.539×(ln(age)))+(0.207×waist)+(1.957×(ln(tg)))−10.074. 4 BMI was categorized as underweight/normal weight (< 85th percentile), overweight (85th to <95th percentile), or obese ( ≥ 95th percentile).
Statistical Analyses
We log-transformed variables that were not normally distributed. We used Wald tests to compare characteristics by level (normal vs. elevated) of ALT, AST, GGT, and PNFI. We compared the percentage of participants who had elevated levels of ALT, AST, GGT, PNFI, fasting glucose, HbA1c, or HOMA-IR across categories of age, sex, BMI, Mexican background, and Hispanic/Latino background using a Wald test of joint significance from logistic regression. Supplemental analyses were stratified by sex, pubertal status, and BMI category.
We used Poisson regression with robust variance to assess the association of HOMA-IR, fasting glucose, and HbA1c (as continuous variables) with elevated ALT, AST, 
RESULTS
Among 1317 participants, mean age was 12.2 years, 51% were male, and 46% were overweight or obese. Participants who were male, overweight/obese, or had elevated waist circumference were more likely to have elevated levels of liver enzymes and PNFI (Table 1) . Those with elevated liver enzymes and elevated PNFI were more likely to have lipid abnormalities (higher levels of total cholesterol, lowdensity lipoprotein cholesterol, and triglycerides, and lower levels of high-density lipoprotein cholesterol), higher levels of inflammation (as measured by higher hs-CRP), lower levels of adiponectin, greater endothelial dysfunction (higher levels of PAI-1 and e-selectin), and more insulin resistance (as measured by higher HOMA-IR) ( Table 1) .
Boys were more likely than girls to have elevated liver enzymes and hyperglycemia (as measured by fasting glucose (Table 2 ). Higher levels of HbA1c were associated with elevated ALT and PNFI in minimally adjusted models, but associations were not statistically significant in fully adjusted models (Fig. 1) . We did not observe any associations of fasting glucose with elevated liver enzymes and PNFI. Associations of HOMA-IR with elevated liver enzymes and PNFI were statistically significant and remained so after full adjustment (model 3) [prevalence ratios (PRs) (95% confidence intervals CIs) were 1.99 (1.40-2.81), 2.15 (1.12-4.12), 1.70 (1.26-2.30), and 1.98 (1.43-2.74) for ALT, AST, GGT, and PNFI, respectively] (Fig. 1) . Sensitivity analyses using liver enzymes and PNFI as continuous variables in linear regression models yielded similar results (eTable 2, Supplemental Digital Content 1, http://links.lww.com/JCG/A366).
We observed statistically significant interactions between BMI (overweight/obese vs. under/normal weight) and HOMA-IR in association with elevated liver enzymes (P = 0.04 for elevated AST and P = 0.07 for elevated GGT). In multivariable models that were stratified by BMI category, we found no statistically significant association of HOMA-IR with elevated liver enzymes in under/normal weight children. However, we observed consistent statistically significant associations in those who were overweight or obese [PRs (95% CIs) were 2.40 (1.61-3.58), 4.50 (2.14-9.48), 1.75 (1.34-2.29), and 3.12 (2.39-4.05) for elevated ALT, AST, GGT, and PNFI, respectively] ( Table 3) . Results were attenuated after adjustment for adiponectin, but remained statistically significant. Additional sequential adjustment for ln of hs-CRP, e-selectin, and ln of PAI-1 continued to weaken the observed association between HOMA-IR and liver enzymes/PNFI in overweight or obese children. After full adjustment, FIGURE 1. Associations of insulin resistance and hyperglycemia with elevated liver enzymes and PNFI. Elevated liver enzymes were defined as ALT > 25 U/L for boys and > 22 U/L for girls, AST ≥ 37 U/ L, GGT ≥ 17 U/L. Elevated PNFI was defined as ≥ 9. Prevalence ratios were obtained using Poisson regression models with robust variance. We specified the models as follows: model 1 (unadjusted); model 2 (sociodemographics): model 1 + age, sex, Mexican background, field center, household income, and parental education; model 3 (traditional risk factors): model 2 + moderate/vigorous activity, elevated waist circumference, BMI percentile, systolic blood pressure percentile, LDL-c, HDL-c, ln of triglycerides, and pubertal status. Models for PNFI were not adjusted for age, waist circumference, or triglycerides, as PNFI is calculated using these variables. ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CI, confidence interval; GGT, gamma-glutamyl transpeptidase; HbA1c, hemoglobin A1c; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-c, low-density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease; PNFI, pediatric NAFLD fibrosis index. *The model for PNFI does not include adjustment for age, waist circumference, or triglyceride levels. †The base model includes adjustment for age, sex, household income, parental education, Mexican background, field center, physical activity, SBP percentile, LDL-c, HDL-c, ln of triglycerides, and pubertal status.
Bold values indicate P < 0.05. ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CI, confidence interval; GGT, gamma-glutamyl transpeptidase; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, Homeostasis Model Assessment of Insulin Resistance; hs-CRP, high-sensitivity C-reactive protein; LDL-c, low-density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease; PAI-1, plasminogen activator inhibitor-1; PNFI, pediatric NAFLD fibrosis index; PR, prevalence ratio; SBP, systolic blood pressure. associations for elevated ALT and GGT were no longer statistically significant [PRs (95% CIs) were 1.20 (0.74-1.96) and 1.26 (0.91-1.73), respectively] (Table 3) . In a sensitivity analysis that restricted to participants who did not report alcohol consumption in the previous 30 days, results were similar, although magnitudes of association were slightly attenuated (eTable 3, Supplemental Digital Content 1, http:// links.lww.com/JCG/A366).
DISCUSSION
Among 8-to 16-year-old children of Hispanic/Latino background, insulin resistance was associated with elevated liver enzymes and PNFI. These associations were only seen in children who were overweight or obese and only remained statistically significant for AST and PNFI after mutual adjustment for several biomarkers of glucose homeostasis, inflammation, and endothelial dysfunction. Our findings suggest that liver disease may begin to develop early in the life course among obese children, and may be related to the development of insulin resistance and diabetes risk. This suggests an important focus for prevention and awareness in young Hispanics/Latinos, a population that has a high prevalence of overweight/obesity.
ALT and AST are intracellular enzymes located in the hepatocytes, although AST is less specific to hepatocytes and is abundant in muscle tissue, red blood cells, and other tissues. When detected in circulation, they indicate enzyme leakage due to liver injury. Elevated levels of GGT are associated with biliary disease and, in 1 pediatric study, directly correlate with the degree of hepatic fibrosis. 40, 41 The PNFI is a noninvasive index of fibrosis that has been assessed in children. 4 However, it should be noted that children with elevated PNFI may not actually have NAFLD, and that associations of obesity-related insulin resistance with NAFLD could potentially be attributed to associations with central adiposity, which is part of the definition of PNFI. ALT levels have been shown to be highest in Hispanic/Latino adolescents compared with those of other races/ethnicities, 24, 25 and higher in males than females, 24 suggesting more liver damage among Hispanics/ Latinos and among males. We observed here that boys were more likely to have elevated liver enzymes than girls.
The mechanism by which insulin resistance may be associated with elevated liver enzymes has not been fully delineated. The liver plays a major role in glucose metabolism. Conversely, it has been hypothesized that insulin resistance may increase both lipogenesis and the amount of free fatty acids in the liver, resulting in increased hepatic fat accumulation. This, in turn, may lead to liver injury. 1, 23, 40, 42 Hyperglycemia, inflammation, and decreased endothelial function may contribute to hepatocyte injury independently. Alternatively, hyperglycemia may induce inflammation and endothelial dysfunction, 43 which may in turn lead to decreased liver function. 23, 44 We demonstrated that sequential adjustment for biomarkers of inflammation and endothelial dysfunction attenuated the association of HOMA-IR with elevated liver enzymes, which suggests that they may be in the pathway between insulin resistance and liver injury. Furthermore, the relationship between insulin resistance and elevated liver enzymes may not be linear, and may propagate a cycle of worsening liver disease and insulin resistance. 20 We did not observe an association of glycemia with liver enzyme elevation in our analysis. Our study population consisted of children and adolescents, and the levels of glycemia may not have been great enough to see an association even if it were to exist. Furthermore, HOMA-IR is a better early detector of glucose homeostasis abnormalities than either fasting glucose or HbA1c, as it precedes hyperglycemia, 45, 46 which may explain the consistency of associations we saw for HOMA-IR with liver enzymes and PNFI. Indeed, insulin resistance tends to be exacerbated during adolescence. During puberty, levels of growth hormone, insulin-like growth factor-1 (IGF-1), and other related hormones are high, and a limitation of this study is the lack of measurements that may have captured the influence of these variables on the relationship between insulin resistance and NAFLD. Further studies may be able to help identify the specific period of adolescence that may be associated with the greatest risk for developing NAFLD and its metabolic sequelae.
There were several strengths and limitations of this analysis to consider. This was a cross-sectional study, so we were unable to address temporality of these relationships and could not distinguish between mediators and confounders. We were unable to include 2-hour glucose results as one of the measures of glycemia. Nor were we able to use a euglycemic hyperinsulinemic clamp technique to directly estimate insulin resistance. However, this technique is challenging to use in large epidemiologic studies and is less relevant in clinical practice. The use of HOMA-IR as a surrogate measure is justified by its linear relationship with estimates of insulin resistance as measured by the glucose clamp. 47 Lastly, liver enzymes and PNFI are not diagnostic of NAFLD. Nonetheless, they are commonly used noninvasive surrogate markers of NAFLD. An important strength of this study was that the sample was populationbased and drawn from a heterogenous mix of children and adolescents from various Hispanic/Latino backgrounds. SOL Youth is unique in that it is one of the largest studies of cardiometabolic health in Hispanic/Latino children. In the pediatric population, it is relatively uncommon for external insults such as alcohol consumption or viral liver infection to affect liver enzyme levels, and we had available an array of clinical and behavioral variables to control for confounding. Furthermore, we showed similar results among those children and adolescents who had not recently consumed alcohol.
CONCLUSIONS
In conclusion, we found that Hispanic/Latino children and adolescents had a high prevalence of elevated liver enzymes in general, and that the prevalence was particularly high in those who were male, overweight/obese, or exhibited central adiposity. Insulin resistance was associated with surrogate markers of NAFLD in overweight or obese Hispanic/Latino children and adolescents, and this association was partially mediated by inflammation and endothelial dysfunction. Furthermore, associations were consistent across Hispanic/Latino background. This suggests a potential target for prevention of liver disease in Hispanic/Latino youth, which is particularly important given the high prevalence of liver damage in Hispanic/Latino adults. Identifying overweight or obese Hispanic/Latino children and adolescents with insulin resistance could help detect those who are at highest risk for developing NAFLD. Further longitudinal study of these associations could better elucidate the temporal relationship between obesity, insulin resistance, and liver
